Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP182420.RA7eWf5E_Pb5riLR_jVRMbfQMus9Ehk4utFArHCKoAKjE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP182420.RA7eWf5E_Pb5riLR_jVRMbfQMus9Ehk4utFArHCKoAKjE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP182420.RA7eWf5E_Pb5riLR_jVRMbfQMus9Ehk4utFArHCKoAKjE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP182420.RA7eWf5E_Pb5riLR_jVRMbfQMus9Ehk4utFArHCKoAKjE130_provenance.
- NP182420.RA7eWf5E_Pb5riLR_jVRMbfQMus9Ehk4utFArHCKoAKjE130_assertion description "[We used the allelic discrimination method to identify polymorphisms in GSTT1, SULT1C2, CDA, SXR (drug metabolic pathways), XPD, XPA, XPG, ERCC1, TOP2A (DNA repair), VEGF (angiogenesis), and MDR1 (multidrug resistance) genes in 110 adult patients with intermediate-risk AML, enrolled in the CETLAM-99 prospective trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP182420.RA7eWf5E_Pb5riLR_jVRMbfQMus9Ehk4utFArHCKoAKjE130_provenance.
- NP182420.RA7eWf5E_Pb5riLR_jVRMbfQMus9Ehk4utFArHCKoAKjE130_assertion evidence source_evidence_literature NP182420.RA7eWf5E_Pb5riLR_jVRMbfQMus9Ehk4utFArHCKoAKjE130_provenance.
- NP182420.RA7eWf5E_Pb5riLR_jVRMbfQMus9Ehk4utFArHCKoAKjE130_assertion SIO_000772 16507781 NP182420.RA7eWf5E_Pb5riLR_jVRMbfQMus9Ehk4utFArHCKoAKjE130_provenance.
- NP182420.RA7eWf5E_Pb5riLR_jVRMbfQMus9Ehk4utFArHCKoAKjE130_assertion wasDerivedFrom befree-20140225 NP182420.RA7eWf5E_Pb5riLR_jVRMbfQMus9Ehk4utFArHCKoAKjE130_provenance.
- NP182420.RA7eWf5E_Pb5riLR_jVRMbfQMus9Ehk4utFArHCKoAKjE130_assertion wasGeneratedBy ECO_0000203 NP182420.RA7eWf5E_Pb5riLR_jVRMbfQMus9Ehk4utFArHCKoAKjE130_provenance.
- befree-20140225 importedOn "2014-02-25" NP182420.RA7eWf5E_Pb5riLR_jVRMbfQMus9Ehk4utFArHCKoAKjE130_provenance.